Data as of Sep 30, 2026, 6:36 AM
Snapshot 2026-09-30
Healthcare members disclosed est. $161.4M (3% of snapshot sectors volume), 10 of 21 — vs Basic Materials $36.5M, Communication Services $181.7M, Consumer Cyclical $214.2M, Consumer Defensive $114.3M, Cryptocurrency $790.5k, Energy $129.9M, Equity $411.1M, ETF $633.0M, Financial Services $713.6M, Fixed income $394.8M, Government $66.1M, Industrials $160.7M, Municipal $1.2B, Non-Public Stock $405.4M, Options $13.9M, Private municipal $40.3M, Real Estate $42.7M, Technology $1.0B, Unclassified $70.4M, Utilities $34.0M.
$142.4M
2,625 trades
$2.1M
56 trades
$1.7M
209 trades
$1.6M
199 trades
$1.4M
10 trades
$1.1M
142 trades
$998.0k
59 trades
$929.0k
71 trades
$750.0k
6 trades
$664.0k
83 trades
$592.0k
74 trades
$408.0k
51 trades
$392.0k
49 trades
$336.0k
42 trades
$320.0k
40 trades
$20.9M
186 trades
$8.6M
141 trades
$8.5M
112 trades
$6.8M
89 trades
$6.3M
154 trades
$6.2M
106 trades
$5.7M
87 trades
$4.9M
117 trades
$4.5M
92 trades
$4.2M
126 trades
$3.3M
77 trades
$3.2M
98 trades
$2.7M
72 trades
$2.6M
72 trades
$2.5M
81 trades
| Traded issuer | Sector | Type | Size | Traded | Trade price | Yesterday | Published | Filed after |
|---|---|---|---|---|---|---|---|---|
Novo Nordisk A/SNVO | Healthcare | Sale | $1k–$15k | Sep 10, 2026 | $44.01 | $38.31 | Sep 25, 2026 | 15 days |
IQVIA Holdings Inc.IQV | Healthcare | Sale | $1k–$15k | Sep 8, 2026 | $259.21 | $268.99 | Sep 25, 2026 | 17 days |
Boston Scientific CorporationBSX | Healthcare | Sale | $1k–$15k | Sep 3, 2026 | $46.95 | $43.88 | Sep 25, 2026 | 22 days |
IQVIA Holdings Inc.IQV | Healthcare | Sale | $1k–$15k | Sep 3, 2026 | $271.62 | $268.99 | Sep 25, 2026 | 22 days |
Danaher CorporationDHR | Healthcare | Sale | $1k–$15k | Sep 2, 2026 | $209.91 | $226.11 | Sep 25, 2026 | 23 days |
Novo Nordisk A/SNVO | Healthcare | Sale | $1k–$15k | Aug 31, 2026 | $45.33 | $38.31 | Sep 25, 2026 | 25 days |
Novo Nordisk A/SNVO | Healthcare | Purchase | $1k–$15k | Aug 26, 2026 | $47.19 | $38.31 | Sep 17, 2026 | 22 days |
Johnson & JohnsonJNJ | Healthcare | Sale | $1k–$15k | Aug 27, 2026 | $265.77 | $267.57 | Sep 12, 2026 | 16 days |
Johnson & JohnsonJNJ | Healthcare | Sale | $1k–$15k | Aug 20, 2026 | $267.37 | $267.57* | Sep 11, 2026 | 22 days |
Phreesia, Inc.PHR | Healthcare | Sale | $1k–$15k | Aug 26, 2026 | $11.60 | $10.01 | Sep 10, 2026 | 15 days |
Phreesia, Inc.PHR | Healthcare | Sale | $1k–$15k | Aug 25, 2026 | $11.52 | $10.01 | Sep 10, 2026 | 16 days |
Agios Pharmaceuticals, Inc.AGIO | Healthcare | Purchase | $1k–$15k | Aug 20, 2026 | $33.63 | $33.30 | Sep 10, 2026 | 21 days |
Artivion, Inc.AORT | Healthcare | Purchase | $1k–$15k | Aug 20, 2026 | $27.98 | $22.86 | Sep 10, 2026 | 21 days |
AtriCure, Inc.ATRC | Healthcare | Purchase | $1k–$15k | Aug 20, 2026 | $47.49 | $58.05 | Sep 10, 2026 | 21 days |
Boston Scientific CorporationBSX | Healthcare | Purchase | $1k–$15k | Aug 18, 2026 | $50.47 | $43.88 | Sep 10, 2026 | 23 days |
Insulet CorporationPODD | Healthcare | Purchase | $1k–$15k | Aug 18, 2026 | $148.03 | $132.84 | Sep 10, 2026 | 23 days |
NeoGenomics, Inc.NEO | Healthcare | Purchase | $1k–$15k | Aug 7, 2026 | $16.57 | $18.74 | Sep 10, 2026 | 34 days |
Moderna, Inc.MRNA | Healthcare | Sale | $1k–$15k | Aug 19, 2026 | $174.38 | $203.46 | Sep 9, 2026 | 21 days |
Alnylam Pharmaceuticals, Inc.ALNY | Healthcare | Sale | $1k–$15k | Aug 11, 2026 | $221.20 | $254.07 | Sep 9, 2026 | 29 days |
Labcorp Holdings Inc.LH | Healthcare | Sale | $1k–$15k | Aug 7, 2026 | $319.17 | $308.81* | Sep 9, 2026 | 33 days |
Labcorp Holdings Inc.LH | Healthcare | Sale | $1k–$15k | Aug 6, 2026 | $316.53 | $308.81* | Sep 9, 2026 | 34 days |
Labcorp Holdings Inc.LH | Healthcare | Sale | $1k–$15k | Aug 5, 2026 | $313.96 | $308.81* | Sep 9, 2026 | 35 days |
Amgen Inc.AMGN | Healthcare | Sale | $1k–$15k | Aug 26, 2026 | $440.34 | $423.64 | Sep 5, 2026 | 10 days |
Vertex Pharmaceuticals IncorporatedVRTX | Healthcare | Sale | $1k–$15k | Aug 26, 2026 | $547.29 | $526.73 | Sep 5, 2026 | 10 days |
Zoetis Inc.ZTS | Healthcare | Sale | $1k–$15k | Jul 17, 2026 | $76.56 | $70.30* | Sep 4, 2026 | 49 days |
Artivion, Inc.AORT | Healthcare | Purchase | $1k–$15k | Jul 16, 2026 | $25.73 | $22.86 | Sep 4, 2026 | 50 days |
Vaxcyte, Inc.PCVX | Healthcare | Purchase | $1k–$15k | Jul 16, 2026 | $56.04 | $56.69 | Sep 4, 2026 | 50 days |
BioCryst Pharmaceuticals, Inc.BCRX | Healthcare | Purchase | $1k–$15k | Jul 10, 2026 | $10.45 | $8.27 | Sep 4, 2026 | 56 days |
HealthEquity, Inc.HQY | Healthcare | Purchase | $1k–$15k | Jul 10, 2026 | $94.40 | $87.25 | Sep 4, 2026 | 56 days |
Amgen Inc.AMGN | Healthcare | Sale | $1k–$15k | Aug 12, 2026 | $416.18 | $423.64* | Sep 2, 2026 | 21 days |
Also see Basic Materials · Communication Services · Consumer Cyclical · Consumer Defensive · Cryptocurrency · Energy · Equity · ETF · Financial Services · Fixed income · Government · Industrials · Municipal · Non-Public Stock · Options · Private municipal · Real Estate · Technology · Unclassified · Utilities
Educated guesstimate only. Filings report ranges, not exact sizes. Share counts use the range midpoint (or 1.5× the floor for “Over $X”) and the closing price on the trade date. Open lots are marked to the latest Yahoo Finance close. Cash dividends and split factors are applied while a reconstructed lot is open. Sales with no matching disclosed buy are treated as closing an unseen lot at the sale price (about $0 P/L on that slice). Bonds and rows without a usable ticker are excluded. This is not actual profit.